Medibio (ASX: MEB) (OTC: MDBIF) Mental health & wellness monitoring technologies

David Kaysen CEO Medibio

 

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

David Kaysen CEO Medibio

 

 

 

 

 

Medibio (ASX: MEB) (OTC: MDBIF) CEO Interview with David Kaysen. Mr. Kaysen recently came on board as the new CEO, in this interview he discusses Medibio’s mental health monitoring technologies, ongoing progress towards full-scale commercializing, and his background in running small-cap med-tech companies.  Kaysen sees 2019 as a “very important year for Medibio” with commercialization rollout, capital raising and FDA regulatory approvals.